Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Leonard A. Mermel, Kevin M. Baskin, Niccolò Buetti, Kerry L. LaPlante, Jonas Marschall
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America
10.1086/599376 · 2009
Unresolved referenced work
2019
A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections
10.1371/journal.pone.0037281 · 2012
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement
10.1093/infdis/168.2.400 · 1993
What is the predominant source of intravascular catheter infections?
10.1093/cid/ciq108 · 2011
Models for predicting the risk of bloodstream infections associated with peripherally inserted central venous catheters: a scoping review
10.1371/journal.pone.0333466 · 2025
Risk factors of catheter-associated bloodstream infection: systematic review and meta-analysis
10.1371/journal.pone.0282290 · 2023
Risk factors for catheter-associated bloodstream infection in hemodialysis patients: a meta-analysis
10.1371/journal.pone.0299715 · 2024
Incidence and risk factor for infection of totally implantable venous access port
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
10.1007/s00423-021-02328-0 · 2022
What is the evidence for intraluminal colonization of hemodialysis catheters?
10.1038/ki.2013.527 · 2014
Pre-emptive antimicrobial locks decrease long-term catheter-related bloodstream infections in hemodialysis patients
10.3390/antibiotics11121692 · 2022
Local infection signs at the catheter-insertion site: a large prospective multicentric cohort study
10.1016/j.cmi.2026.06.008 · 2026
Treatment guidelines for dialysis catheter-related bacteremia: an update
10.1053/j.ajkd.2009.04.006 · 2009
Do bacteremic patients with end-stage renal disease have a fever when presenting to the emergency department? A paired, retrospective cohort study
10.1186/s12873-019-0298-2 · 2020
Should blood cultures be drawn through an indwelling catheter?
10.1093/ofid/ofae248 · 2024
Utility of differential time to positivity in diagnosing central line-associated bloodstream infections: a systematic review and meta-analysis
10.1093/cid/ciad225 · 2023
Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis
10.1016/j.jhin.2018.01.010 · 2018
Detection of septic metastases in catheter-related Staphylococcus aureus bacteremia using 18(F)FDG-PET/CT: a before-and-after study
10.1186/s12879-025-11055-6 · 2025
Pediatric central venous access device lock solutions: a network meta-analysis
10.1542/peds.2023-063264 · 2024
Differences in efficacy between antibacterial lock therapy and the standard of care for CVC-related infections: a systematic review and meta-analysis
10.3390/clinpract14040124 · 2024
Prevention of long-term catheter-related bloodstream infection with prophylactic antimicrobial lock solutions: why so little use?
10.1016/j.cmi.2022.11.021 · 2023
Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: when and how to proceed? Guidelines for clinical practice 2020
10.1016/j.idnow.2021.02.004 · 2021
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy
10.1093/jac/dkl318 · 2006
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study
10.1093/jac/dkl103 · 2006
Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin
10.1007/s10096-007-0356-7 · 2007
Unresolved referenced work
Kept as external metadata until matched
Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection
10.1016/j.jinf.2014.01.001 · 2014
In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model
10.1093/ndt/gfm141 · 2007
Antibiotic lock therapy: review of technique and logistical challenges
2014
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
10.1128/aac.00939-06 · 2007
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions
10.2146/ajhp110256 · 2012
Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin
10.1007/s11255-012-0339-1 · 2013
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
10.1086/510386 · 2007
Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution
10.1046/j.1523-1755.2002.00201.x · 2002
Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports)
10.1128/aac.43.8.2074 · 1999
Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy
10.1093/jac/dki311 · 2005
Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin
10.1345/aph.1g446 · 2006
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia
10.1053/j.ajkd.2006.06.012 · 2006
Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method
10.1159/000197560 · 2009
Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter
10.1592/phco.20.5.394.35063 · 2000
Smart catheters for diagnosis, monitoring, and therapy
10.1002/adhm.202503913 · doi-reference
Hydrophilic cationic surface modification confers simultaneous antibacterial and antithrombotic properties to blood-contacting devices
10.1016/j.actbio.2026.03.044 · doi-reference
Co-assembly of zwitterionic and cationic polymers for antibacterial and antithrombotic surfaces via weak electrostatic interactions
10.1016/j.biomaterials.2026.124114 · doi-reference
Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization
10.1097/ccm.0b013e3181f265ba · doi-reference
Antimicrobial efficacy and safety of a novel gas plasma-activated catheter lock solution
10.1128/aac.00744-18 · doi-reference
Clinical features of Candida catheter-related bloodstream infections and persistent infections associated with early catheter reinsertion: a 6-year retrospective study
10.4103/jgid.jgid_17_24 · doi-reference
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials
10.1093/cid/cis021 · doi-reference
Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy
10.1097/inf.0b013e318170b68b · doi-reference
Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control
10.1007/s10096-022-04403-w · doi-reference
Life-threatening chlorhexidine anaphylaxis caused by skin preparation before chlorhexidine-free central venous catheter insertion: a case report and literature review
10.1007/s00540-023-03189-1 · doi-reference
CLABSIs aren’t just for inpatients: the need to identify CLABSI burden among outpatients
10.1017/ash.2024.384 · doi-reference
Improving central line-associated bloodstream infection prevention practices in oncology clinic patients: mobile-app based surveillance & response
10.1017/ice.2025.16 · doi-reference
Decolonization of Staphylococcus aureus
10.1016/j.idc.2020.10.010 · doi-reference
Preventing bloodstream infection in patients receiving home parenteral nutrition
10.1097/mpg.0000000000000419 · doi-reference
Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator
10.1056/nejmoa1011376 · doi-reference
Antimicrobial locks for the prevention of central line associated bloodstream infections in pediatric patients: a systematic review and network meta-analysis
10.1186/s13756-026-01704-z · doi-reference
Cluster-randomized trial of devices to prevent catheter-related bloodstream infection
10.1681/asn.2017080870 · doi-reference
Prevention of intravascular catheter-related infections-25 years later
10.1017/ice.2025.10300 · doi-reference
Prevention of central line-associated bloodstream infections
10.1056/nejmra2213296 · doi-reference
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update
10.1017/ice.2022.87 · doi-reference
Evidence-based strategies and recommendations for preservation of central venous access in children
10.1002/jpen.1591 · doi-reference
Prospective, randomized study of long-term hemodialysis catheter removal versus guidewire exchange to treat catheter-related bloodstream infection
10.1016/j.jvs.2017.05.119 · doi-reference
How long should peripherally inserted central catheterization be delayed in the context of recently documented bloodstream infection?
10.1016/j.jvir.2011.09.024 · doi-reference
Clinical impact of early reinsertion of a central venous catheter after catheter removal in patients with catheter-related bloodstream infections
10.1017/ice.2020.405 · doi-reference
Efficacy of antimicrobial peripherally inserted central catheters in line-associated bloodstream infections: a systematic review and meta-analysis
10.1016/j.ajic.2023.04.163 · doi-reference
Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: a simulation-based pilot study
10.1097/md.0000000000022218 · doi-reference
Antimicrobial elution patterns correlate with antibacterial and antifungal activities of three antimicrobial central venous catheters in serum
10.1128/aac.01920-25 · doi-reference
Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study
10.1016/s0002-9343(03)00367-x · doi-reference
Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial
10.1200/jco.2004.04.124 · doi-reference
Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin
10.1097/00003246-199802000-00015 · doi-reference
The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
10.1186/1471-2334-14-518 · doi-reference
Long-term central venous access in pediatric patients at high risk: conventional versus antibiotic-impregnated catheters
10.1016/j.jvir.2013.11.024 · doi-reference
In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth
10.1093/jac/dkn160 · doi-reference
Combination of systemic and lock-therapies with micafungin eradicate catheter-based biofilms and infections caused by Candida albicans and Candida parapsilosis in neutropenic rabbit models
10.3390/jof10040293 · doi-reference
International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections
10.1080/17434440.2018.1483237 · doi-reference
Minocycline-EDTA-ethanol antimicrobial catheter lock solution is highly effective in vitro for eradication of Candida auris biofilms
10.1128/aac.02146-19 · doi-reference
Successful salvage of central venous catheters in patients with catheter-related or central line-associated bloodstream infections by using a catheter lock solution consisting of minocycline, EDTA, and 25% ethanol
10.1128/aac.02565-15 · doi-reference
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm
10.1128/aac.00154-06 · doi-reference
Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections
10.1086/514518 · doi-reference
Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer
10.1086/344952 · doi-reference